Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dolby Laboratories (DLB) EBT (2016 - 2025)

Dolby Laboratories (DLB) has disclosed EBT for 17 consecutive years, with $71.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 16.79% year-over-year to $71.6 million, compared with a TTM value of $289.0 million through Dec 2025, down 9.02%, and an annual FY2025 reading of $303.5 million, down 2.88% over the prior year.
  • EBT was $71.6 million for Q4 2025 at Dolby Laboratories, up from $41.7 million in the prior quarter.
  • Across five years, EBT topped out at $121.7 million in Q1 2024 and bottomed at $9.0 million in Q3 2023.
  • Average EBT over 5 years is $67.0 million, with a median of $59.4 million recorded in 2021.
  • The sharpest move saw EBT crashed 70.84% in 2023, then soared 561.29% in 2024.
  • Year by year, EBT stood at $91.4 million in 2021, then grew by 9.34% to $100.0 million in 2022, then dropped by 19.15% to $80.8 million in 2023, then increased by 6.46% to $86.1 million in 2024, then fell by 16.79% to $71.6 million in 2025.
  • Business Quant data shows EBT for DLB at $71.6 million in Q4 2025, $41.7 million in Q3 2025, and $55.5 million in Q2 2025.